Literature DB >> 2358296

Molecular analyses of a Lesch-Nyhan syndrome mutation (hprtMontreal) by use of T-lymphocyte cultures.

T R Skopek1, L Recio, D Simpson, L Dallaire, S B Melancon, H Ogier, J P O'Neill, M T Falta, J A Nicklas, R J Albertini.   

Abstract

The frequency of hprt mutants in peripheral blood T-lymphocytes of two putative Lesch-Nyhan individuals and their parents was determined by a cell cloning assay to quantify the frequency of thioguanine-resistant mutants. The results confirmed the Lesch-Nyhan diagnosis and demonstrated that the mother has an elevated mutant frequency consistent with being heterozygous for an hprt mutation. Mass cultures of T-lymphocytes from both the children and their mother, as well as cultures of hprt mutant clones from the mother, were employed as sources of mRNA for cDNA sequence analysis. These hprt mutants show a single base substitution (T----C transition) at position 170 (exon 3). The predicted amino acid change is the substitution of threonine for methionine56. We have designated this new Lesch-Nyhan mutation hprtMontreal. The use of T-lymphocyte cultures allows rapid sequence analyses of hprt mutations, as well as family studies to define the origin of a particular mutation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2358296     DOI: 10.1007/bf00276334

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  37 in total

1.  Longitudinal study of the in vivo hprt mutant frequency in human T-lymphocytes as determined by a cell cloning assay.

Authors:  J P O'Neill; L M Sullivan; J K Booker; B S Pornelos; M T Falta; C J Greene; R J Albertini
Journal:  Environ Mol Mutagen       Date:  1989       Impact factor: 3.216

2.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

3.  Molecular analyses of in vivo hprt mutations in human T-lymphocytes. I. Studies of low frequency 'spontaneous' mutants by Southern blots.

Authors:  J A Nicklas; T C Hunter; L M Sullivan; J K Berman; J P O'Neill; R J Albertini
Journal:  Mutagenesis       Date:  1987-09       Impact factor: 3.000

4.  Inherited disorder of purine metabolism. Correlation between central nervous system dysfunction and biochemical defects.

Authors:  F M Rosenbloom; W N Kelley; J Miller; J F Henderson; J E Seegmiller
Journal:  JAMA       Date:  1967-10-16       Impact factor: 56.272

5.  Human hypoxanthine-guanine phosphoribosyltransferase: a single nucleotide substitution in cDNA clones isolated from a patient with Lesch-Nyhan syndrome (HPRTMidland).

Authors:  B L Davidson; T D Palella; W N Kelley
Journal:  Gene       Date:  1988-08-15       Impact factor: 3.688

6.  Molecular evidence for new mutation at the hprt locus in Lesch-Nyhan patients.

Authors:  T P Yang; P I Patel; A C Chinault; J T Stout; L G Jackson; B M Hildebrand; C T Caskey
Journal:  Nature       Date:  1984 Aug 2-8       Impact factor: 49.962

7.  Human hypoxanthine-guanine phosphoribosyltransferase.

Authors:  J M Wilson; R Kobayashi; I H Fox; W N Kelley
Journal:  J Biol Chem       Date:  1983-05-25       Impact factor: 5.157

8.  Mutagenicity monitoring in humans by autoradiographic assay for mutant T lymphocytes.

Authors:  R J Albertini; L M Sullivan; J K Berman; C J Greene; J A Stewart; J M Silveira; J P O'Neill
Journal:  Mutat Res       Date:  1988-03       Impact factor: 2.433

9.  Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyl transferase.

Authors:  D J Jolly; H Okayama; P Berg; A C Esty; D Filpula; P Bohlen; G G Johnson; J E Shively; T Hunkapillar; T Friedmann
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

10.  Genetic basis of hypoxanthine guanine phosphoribosyltransferase deficiency in a patient with the Lesch-Nyhan syndrome (HPRTFlint).

Authors:  B L Davidson; M Pashmforoush; W N Kelley; T D Palella
Journal:  Gene       Date:  1988-03-31       Impact factor: 3.688

View more
  5 in total

1.  Eighteen-year follow-up of a patient with partial hypoxanthine phosphoribosyltransferase deficiency and a new mutation.

Authors:  Alojz Gregoric; Gwenda M Rabelink; Nadja Kokalj Vokac; Natasa Marcun Varda; Boris Zagradisnik
Journal:  Pediatr Nephrol       Date:  2005-06-18       Impact factor: 3.714

2.  Molecular basis of hypoxanthine-guanine phosphoribosyltransferase deficiency in Italian Lesch-Nyhan patients: identification of nine novel mutations.

Authors:  M Bertelli; D Randi; V Micheli; S Gallo; G Andrighetto; P Parmigiani; G Jacomelli; M Carella; C Lievore; M Pandolfo
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

3.  Selection against blood cells deficient in hypoxanthine phosphoribosyltransferase (HPRT) in Lesch-Nyhan heterozygotes occurs at the level of multipotent stem cells.

Authors:  M Hakoda; Y Hirai; M Akiyama; H Yamanaka; C Terai; N Kamatani; S Kashiwazaki
Journal:  Hum Genet       Date:  1995-12       Impact factor: 4.132

Review 4.  A review of the molecular basis of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency.

Authors:  D G Sculley; P A Dawson; B T Emmerson; R B Gordon
Journal:  Hum Genet       Date:  1992-11       Impact factor: 4.132

5.  Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency: identification of point mutations in Japanese patients with Lesch-Nyhan syndrome and hereditary gout and their permanent expression in an HPRT-deficient mouse cell line.

Authors:  J Tohyama; E Nanba; K Ohno
Journal:  Hum Genet       Date:  1994-02       Impact factor: 4.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.